A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation. Zhao D, Guo Z, Zhao G, Sa R, et al. Transpl Int 2023;36:11771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao D, Guo Z, Zhao G, Sa R, et al. A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation. Transpl Int 2023;36:11771.
PMID: 37675269